AstraZenca Pharma India Ltd. | ASTRAZEN | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2018
2019
2020
2021
Revenue
Revenue
5,7107,2838,3188,264
Cost of revenue
Cost of revenue
-1,811-2,311-3,052-2,950
Gross Profit
Gross Profit
3,899
4,972
5,266
5,315
Sales, general & ad...
Sales, general and administrative
-3,436-4,224-4,043-3,804
Depreciation
Depreciation and amortization
-147-149-186-201
Provision
Provision
0-35-160
Other op inc/exp...
Other operating income/expenses
000-27
Operating income
Operating income EBIT
316
564
1,021
1,282
 
     
Profit before tax
Profit before tax
4387271,1401,271
Net Income
Net income
259
545
722
933
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
10.36
21.78
28.88
37.32